All filters
Videos
Roundtable discussion: Trial design, treatment endpoints and regulatory approach
Presented at:
International Workshop on HBV Cure 2017
Videos
Innovative trial design | Henry Lik Yuen Chan
Presented at:
International Workshop on HBV Cure 2017
Videos
Combination therapy how to navigate in a minefield of efficacy and toxicity? | Jordan Feld, MD, MPH
Presented at:
International Workshop on HBV Cure 2017
Videos
Other virological mechanisms | Stephen Locarnini, BSc, PhD, MBBS, FRCP
Presented at:
International Workshop on HBV Cure 2017
Videos
RNA interference | Bill Symonds, PharmD
Presented at:
International Workshop on HBV Cure 2017
Videos
CCC – DNA inhibition | Anuj Gaggar, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Videos
Innate Immunity : TLR, RIG-I, STING and potential others | Adam Gehring, PhD
Presented at:
International Workshop on HBV Cure 2017
Videos
How does HBV interact with the immune system | Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Videos
Is immunomodulation really needed to cure HBV? | Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Videos
Hepatitis B Cure: From Discovery to Regulatory Endpoints in HBV clinical research: A summary of the AASLD/EASL statement | Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Videos
TAF – The latest update, which questions remain to be answered? | Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
TAF – The latest update, which questions remain to be answered?- Pietro Lampertico, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Hepatitis B Cure: From Discovery to Regulatory Endpoints in HBV clinical research: A summary of the AASLD/EASL statement- Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
How does HBV interact with the immune system- Mala Maini, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Is immunomodulation really needed to cure HBV?- Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Innate Immunity : TLR, RIG-I, STING and potential others- Adam Gehring, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Adaptive Immunity: Therapeutic vaccination, checkpoint inhibition and potential others- Andre Boonstra, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Entry inhibition- Stephan Urban, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
CCC – DNA inhibition- Anuj Gaggar, MD, PhD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
RNA interference- Bill Symonds, PharmD
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Other virological mechanisms- Stephen Locarnini, BSc, PhD, MBBS, FRCP
Presented at:
International Workshop on HBV Cure 2017
Slidesets
Innovative trial design- Henry Lik Yuen Chan
Presented at:
International Workshop on HBV Cure 2017